Excretion of Tiglylglycine in Propionic Acidemia
Overview
Affiliations
Biomarkers for drug development in propionic and methylmalonic acidemias.
Longo N, Sass J, Jurecka A, Vockley J J Inherit Metab Dis. 2022; 45(2):132-143.
PMID: 35038174 PMC: 9303879. DOI: 10.1002/jimd.12478.
Haijes H, Jans J, van der Ham M, van Hasselt P, Verhoeven-Duif N Orphanet J Rare Dis. 2020; 15(1):68.
PMID: 32143654 PMC: 7060614. DOI: 10.1186/s13023-020-1347-3.
Przyrembel H, Bremer H, Duran M, Bruinvis L, Ketting D, WADMAN S Eur J Pediatr. 1979; 130(1):1-14.
PMID: 759179 DOI: 10.1007/BF00441893.
Coude F, Sweetman L, Nyhan W J Clin Invest. 1979; 64(6):1544-51.
PMID: 500823 PMC: 371306. DOI: 10.1172/JCI109614.
N-Dicarboxylmonoglycines: excretion in dicarboxylic acidurias and mode of formation.
Gron I, Gregersen N, Rasmussen K J Inherit Metab Dis. 1978; 1(3):109-10.
PMID: 116078 DOI: 10.1007/BF01805684.